These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 16061727)

  • 1. Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers.
    Cobbold M; Khan N; Pourgheysari B; Tauro S; McDonald D; Osman H; Assenmacher M; Billingham L; Steward C; Crawley C; Olavarria E; Goldman J; Chakraverty R; Mahendra P; Craddock C; Moss PA
    J Exp Med; 2005 Aug; 202(3):379-86. PubMed ID: 16061727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA tetramers and anti-CMV immune responses: from epitope to immunotherapy.
    Chen FE; Aubert G; Travers P; Dodi IA; Madrigal JA
    Cytotherapy; 2002; 4(1):41-8. PubMed ID: 11953040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification of cytomegalovirus-specific CD8 T cells from peripheral blood using HLA-peptide tetramers.
    Keenan RD; Ainsworth J; Khan N; Bruton R; Cobbold M; Assenmacher M; Milligan DW; Moss PA
    Br J Haematol; 2001 Nov; 115(2):428-34. PubMed ID: 11703346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein-Barr virus-specific T cells as targets of interest in immunotherapeutic approaches.
    Tischer S; Dieks D; Sukdolak C; Bunse C; Figueiredo C; Immenschuh S; Borchers S; Stripecke R; Maecker-Kolhoff B; Blasczyk R; Eiz-Vesper B
    J Immunol Methods; 2014 Jun; 408():101-13. PubMed ID: 24877879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refining human T-cell immunotherapy of cytomegalovirus disease: a mouse model with 'humanized' antigen presentation as a new preclinical study tool.
    Lemmermann NA; Reddehase MJ
    Med Microbiol Immunol; 2016 Dec; 205(6):549-561. PubMed ID: 27539576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tetramer monitoring to assess risk factors for recurrent cytomegalovirus reactivation and reconstitution of antiviral immunity post allogeneic hematopoietic stem cell transplantation.
    Borchers S; Luther S; Lips U; Hahn N; Kontsendorn J; Stadler M; Buchholz S; Diedrich H; Eder M; Koehl U; Ganser A; Mischak-Weissinger E
    Transpl Infect Dis; 2011 Jun; 13(3):222-36. PubMed ID: 21585633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-ordinated isolation of CD8(+) and CD4(+) T cells recognizing a broad repertoire of cytomegalovirus pp65 and IE1 epitopes for highly specific adoptive immunotherapy.
    Zandvliet ML; van Liempt E; Jedema I; Veltrop-Duits LA; Willemze R; Guchelaar HJ; Falkenburg JH; Meij P
    Cytotherapy; 2010 Nov; 12(7):933-44. PubMed ID: 20078388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble recombinant CMVpp65 spanning multiple HLA alleles for reconstitution of antiviral CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation.
    Paine A; Oelke M; Tischer S; Heuft HG; Blasczyk R; Eiz-Vesper B
    J Immunother; 2010 Jan; 33(1):60-72. PubMed ID: 19952955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A modified peptide stimulation method for efficient amplification of cytomegalovirus (CMV)-specific CTLs.
    Ruan GP; Ma L; Wen Q; Luo W; Zhou MQ; Wang XN
    Cell Mol Immunol; 2008 Jun; 5(3):197-201. PubMed ID: 18582401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro expansion of polyclonal T-cell subsets for adoptive immunotherapy by recombinant modified vaccinia Ankara.
    La Rosa C; Wang Z; Lacey SF; Lalimarmo MM; Krishnan A; Longmate J; Diamond DJ
    Exp Hematol; 2006 Apr; 34(4):497-507. PubMed ID: 16569596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytomegalovirus-Mediated T Cell Receptor Repertoire Perturbation Is Present in Early Life.
    Attaf M; Roider J; Malik A; Rius Rafael C; Dolton G; Predergast AJ; Leslie A; Ndung'u T; Kløverpris HN; Sewell AK; Goulder PJ
    Front Immunol; 2020; 11():1587. PubMed ID: 33101265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective immunity transferred by infusion of cytomegalovirus-specific CD8(+) T cells within donor grafts: its associations with cytomegalovirus reactivation following unmanipulated allogeneic hematopoietic stem cell transplantation.
    Luo XH; Huang XJ; Liu KY; Xu LP; Liu DH
    Biol Blood Marrow Transplant; 2010 Jul; 16(7):994-1004. PubMed ID: 20167279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmentation of virus-specific immunity after hematopoietic stem cell transplantation by adoptive T-cell therapy.
    Peggs KS; Mackinnon S
    Hum Immunol; 2004 May; 65(5):550-7. PubMed ID: 15172456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy.
    Einsele H; Roosnek E; Rufer N; Sinzger C; Riegler S; Löffler J; Grigoleit U; Moris A; Rammensee HG; Kanz L; Kleihauer A; Frank F; Jahn G; Hebart H
    Blood; 2002 Jun; 99(11):3916-22. PubMed ID: 12010789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid generation of combined CMV-specific CD4+ and CD8+ T-cell lines for adoptive transfer into recipients of allogeneic stem cell transplants.
    Rauser G; Einsele H; Sinzger C; Wernet D; Kuntz G; Assenmacher M; Campbell JD; Topp MS
    Blood; 2004 May; 103(9):3565-72. PubMed ID: 14670917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus-specific CD8(+) T cells targeting different HLA/peptide combinations correlate with protection but at different threshold frequencies.
    Giest S; Grace S; Senegaglia AC; Pasquini R; Gonzalo-Daganzo RM; Fernández MN; Mackinnon S; Madrigal JA; Travers PJ
    Br J Haematol; 2010 Jan; 148(2):311-22. PubMed ID: 20095088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines.
    Peggs KS; Verfuerth S; Pizzey A; Khan N; Guiver M; Moss PA; Mackinnon S
    Lancet; 2003 Oct; 362(9393):1375-7. PubMed ID: 14585640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cytomegalovirus specific cytotoxic T lymphocytes for treatment of refractory cytomegalovirus infection in patients following allogeneic hematopoietic stem cell transplantation].
    Xu Z; Huang X; Sun Y; Wang F; Yan C; Zhang X; Han W; Chen Y; Wang J; Chen H; Wang Y; Zhang Y; Liu K; Xu L
    Zhonghua Nei Ke Za Zhi; 2015 Feb; 54(2):101-5. PubMed ID: 25907838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detailed analysis of cytomegalovirus (CMV)-specific T cells expanded for adoptive immunotherapy of CMV infection following allogeneic stem cell transplantation for malignant disease.
    Hobeika A; Osada T; Serra D; Peplinski S; Hanson K; Tanaka Y; Niedzwiecki D; Chao N; Rizzieri D; Lyerly H; Clay T; Morse M
    Cytotherapy; 2008; 10(3):289-302. PubMed ID: 18418774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen-Specific TCR Signatures of Cytomegalovirus Infection.
    Huth A; Liang X; Krebs S; Blum H; Moosmann A
    J Immunol; 2019 Feb; 202(3):979-990. PubMed ID: 30587531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.